Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NYAX | CMRE |
|---|---|---|
| Price | $49.77 | $15.39 |
| Change today | ▲ 1.57% | ▼ 0.32% |
| Market cap | $1.86B | $1.86B |
| Return, 3 months | -24.6% | +7.0% |
| Return, year to date | -1.6% | -1.1% |
| Return, 1 year | +4.1% | +32.8% |
| P/E (TTM) | 238.1 | 5.8 |
| P/B | 7.6 | 0.8 |
| P/E percentile vs own 5y | 93rd | 82nd |
| Dividend yield | – | 2.99% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +49.7% | – |
| Analyst buy share | 60% | – |
| RSI (14) | 55 | 57 |
| 30-day volatility | 54.8% | 30.5% |
| Max drawdown, 1 year | -43.8% | -21.4% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
